高危患者门诊结肠镜检查后非胃肠道不良事件增加
基于美国商业理赔数据库2010年3月至2012年3月的回顾性纵向分析,比较高危患者(82,025例)与平均风险患者(398,663例)结肠镜检查后1-30天非胃肠道不良事件。服用抗血栓药物者30天非胃肠道不良事件发生率为7.3%(OR 10.75),有肺部合并症者为1.8%(OR 2.44),平均风险患者为0.7%;年龄60-69岁(OR 2.21)和70岁及以上(OR 6.45)风险升高。
要点
- 服用抗血栓药物者结肠镜后30天非胃肠道不良事件OR为10.75(95%CI 10.13-11.42)
- 有肺部合并症者OR为2.44(95%CI 2.27-2.62),平均风险患者发生率为0.7%
- 年龄60-69岁OR为2.21(95%CI 2.01-2.42),70岁及以上OR为6.45(95%CI 5.89-7.06)
核心结论
- 合并症数量增加和年龄大于60岁与结肠镜检查后非胃肠道不良事件风险增加相关。
- 作者认为这些发现表明在结肠镜检查前确定合并症风险和评估抗血栓管理的重要性。
研究设计与样本
- 回顾性纵向分析,评估美国商业理赔数据库(2010年3月至2012年3月)中的诊断、操作和处方药代码。
- 高危患者82,025例(定义为有肺部合并症或需要抗血栓药物治疗的心血管疾病)与平均风险患者398,663例进行比较。
- 1:1匹配分析中,51,932例接受结肠镜检查的高危患者与51,932例按年龄、性别和合并症匹配的未接受结肠镜检查的高危患者进行比较。
- 追踪结肠镜检查后1-30天的心脏、肺和神经血管事件。
主要发现
- 门诊结肠镜检查后30天,服用抗血栓药物者非胃肠道不良事件发生率为7.3%(OR 10.75;95%CI 10.13-11.42),有肺部合并症者为1.8%(OR 2.44;95%CI 2.27-2.62),平均风险患者为0.7%。
- 与50岁以下患者相比,60-69岁患者OR为2.21(95%CI 2.01-2.42),70岁及以上患者OR为6.45(95%CI 5.89-7.06)。
- 接受结肠镜检查的高危患者30天非胃肠道不良事件发生率显著高于匹配的未接受结肠镜检查的高危患者:抗凝药组OR为2.31(95%CI 2.01-2.65),慢性阻塞性肺疾病组OR为1.33(95%CI 1.13-1.56)。
临床怎么用
- 作者认为这些发现表明在结肠镜检查前确定合并症风险和评估抗血栓管理的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The incidence and predictors of non-gastrointestinal (GI) adverse events (AEs) after colonoscopy are not well-understood. We studied the effects of antithrombotic agents, cardiopulmonary comorbidities, and age on risk of non-GI AEs after colonoscopy. METHODS: We performed a retrospective longitudinal analysis to assess the diagnosis, procedure, and prescription drug codes in a United States commercial claims database (March 2010-March 2012). Data from patients at increased risk (n = 82,025; defined as patients with pulmonary comorbidities or cardiovascular disease requiring antithrombotic medications) were compared with data from 398,663 average-risk patients. In a 1:1 matched analysis, 51,932 patients at increased risk, examined by colonoscopy, were compared with 51,932 matched (on the basis of age, sex, and comorbidities) patients at increased risk who did not undergo colonoscopy. We tracked cardiac, pulmonary, and neurovascular events 1-30 days after colonoscopy. RESULTS: Thirty days after outpatient colonoscopy, non-GI AEs were significantly higher in patients taking antithrombotic medications (7.3%; odds ratio [OR], 10.75; 95% confidence interval, 10.13-11.42) or those with pulmonary comorbidities (1.8%; OR, 2.44; 95% confidence interval, 2.27-2.62) vs average-risk patients (0.7%) and in patients 60-69 years old (OR, 2.21; 95% confidence interval, 2.01-2.42) or 70 years or older (OR, 6.45; 95% confidence interval, 5.89-7.06), compared with patients younger than 50 years. The 30-day incidence of non-GI AEs in patients at increased risk who underwent colonoscopy was also significantly higher than in matched patients at increased risk who did not undergo colonoscopy in the anticoagulant group (OR, 2.31; 95% confidence interval, 2.01-2.65) and in the chronic obstructive pulmonary disease group (OR, 1.33; 95% confidence interval, 1.13-1.56). CONCLUSIONS: Increased number of comorbidities and older age (older than 60 years) are associated with increased risk of non-GI AEs after colonoscopy. These findings indicate the importance of determining comorbid risk and evaluating antithrombotic management before colonoscopy.
引用
- Johnson DA, Lieberman D, Inadomi JM, et al. Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Clin Gastroenterol Hepatol. 2016. PMID: 28017846. doi:10.1016/j.cgh.2016.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。